Rare disorder of the anterior segment of the eye

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Rare disorder of the anterior segment of the eye.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

TOBRADEX ST

Harrow Eye, LLC

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

TOBRADEX ST

(TOBRAMYCIN / DEXAMETHASONE)standard

Harrow Eye, LLC

Corticosteroid [EPC]

12.1 Mechanism of Action Dexamethasone is a potent corticoid. Corticoids suppress the inflammatory response to a variety of agents and they can delay ...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare disorder of the anterior segment of the eye.
Search all trials →
Search clinical trials for Rare disorder of the anterior segment of the eye

Recent News & Research

1 article
BREAKINGFDA

FDA Approves TOBRADEX ST

TOBRADEX ST (DEXAMETHASONE) received FDA approval.

Read ↗

Browse all Rare disorder of the anterior segment of the eye news →

Specialist Network

No specialists currently listed for Rare disorder of the anterior segment of the eye.

View all Rare disorder of the anterior segment of the eye specialists →

Quick Actions